Literature DB >> 7582481

The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.

D W Bonhaus1, C Bach, A DeSouza, F H Salazar, B D Matsuoka, P Zuppan, H W Chan, R M Eglen.   

Abstract

1. Full length clones of the human 5-HT2B receptor were isolated from human liver, kidney and pancreas. The cloned human 5-HT2B receptors had a high degree of homology (approximately 80%) with the rat and mouse 5-HT2B receptors. 2. PCR amplification was used to determine the tissue distribution of human 5-HT2B receptor mRNA. mRNA encoding the 5-HT2B receptor was expressed with greatest abundance in human liver and kidney. Lower levels of expression were detected in cerebral cortex, whole brain, pancreas and spleen. Expression was not detected in heart. 3. Northern blot analysis confirmed the presence of 5-HT2B receptor mRNA (a 2.4 kB sized band) in pancreas, liver and kidney. An additional 3.2 kB sized band of hybridization was detected in liver and kidney. This raises the possibility of a splice variant of the receptor or the presence of an additional homologous receptor. 4. The human 5-HT2B receptor was expressed in Cos-7 cells and its ligand binding characteristics were compared to similarly expressed human 5-HT2A and 5-HT2C receptors. The ligand specificity of the human 5-HT2B receptor (5-HT > ritanserin > SB 204741 > spiperone) was distinct from that of the human 5-HT2A (ritanserin > spiperone > 5-HT > SB 204741) and 5-HT2C (ritanserin > 5-HT > spiperone = SB 204741) receptors. On the basis of a higher affinity for ketanserin and a lower affinity for yohimbine the human 5-HT2B receptor also appeared to differ from the rat 5-HT2B receptor. 5. These findings confirm the sequence of the human 5-HT2B receptor and they demonstrate that the receptor has a widespread tissue distribution. In addition, these data suggest that there are differences in ligand affinities between different species homologues of the receptor. Finally, the finding of two distinct bands on the Northern blots of liver and kidney raises the possibility of splice variants or subtypes of 5-HT2B receptors, within these tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582481      PMCID: PMC1908489          DOI: 10.1111/j.1476-5381.1995.tb14977.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus.

Authors:  J D Kursar; D L Nelson; D B Wainscott; M L Cohen; M Baez
Journal:  Mol Pharmacol       Date:  1992-10       Impact factor: 4.436

2.  N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: the first selective 5-HT1C receptor antagonist.

Authors:  I T Forbes; G A Kennett; A Gadre; P Ham; C J Hayward; R T Martin; M Thompson; M D Wood; G S Baxter; A Glen
Journal:  J Med Chem       Date:  1993-04-16       Impact factor: 7.446

3.  The human serotonin 5-HT2B receptor: pharmacological link between 5-HT2 and 5-HT1D receptors.

Authors:  D S Choi; G Birraux; J M Launay; L Maroteaux
Journal:  FEBS Lett       Date:  1994-10-03       Impact factor: 4.124

4.  Cloning and functional characterization of the human 5-HT2B serotonin receptor.

Authors:  K Schmuck; C Ullmer; P Engels; H Lübbert
Journal:  FEBS Lett       Date:  1994-03-28       Impact factor: 4.124

5.  Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle.

Authors:  G S Baxter; O E Murphy; T P Blackburn
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Gene structure and expression of the mouse 5-HT2 receptor.

Authors:  W Yang; K Chen; N C Lan; T K Gallaher; J C Shih
Journal:  J Neurosci Res       Date:  1992-10       Impact factor: 4.164

7.  Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors.

Authors:  E Glusa; M Richter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

Review 8.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

9.  Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor.

Authors:  J D Kursar; D L Nelson; D B Wainscott; M Baez
Journal:  Mol Pharmacol       Date:  1994-08       Impact factor: 4.436

10.  Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines.

Authors:  D L Nelson; V L Lucaites; J E Audia; J S Nissen; D B Wainscott
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

View more
  71 in total

1.  Evidence that activation of central 5-HT(2B) receptors causes renal sympathoexcitation in anaesthetized rats.

Authors:  I D Knowles; A G Ramage
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptors.

Authors:  E Glusa; H H Pertz
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 3.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

4.  Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo.

Authors:  Martilias Farrell; Sharon Rosenzweig-Lipson; Ellen Walker
Journal:  Psychopharmacology (Berl)       Date:  2010-06-05       Impact factor: 4.530

5.  Serotonergic activity-guided phytochemical investigation of the roots of Angelica sinensis.

Authors:  Shixin Deng; Shao-Nong Chen; Ping Yao; Dejan Nikolic; Richard B van Breemen; Judy L Bolton; Harry H S Fong; Norman R Farnsworth; Guido F Pauli
Journal:  J Nat Prod       Date:  2006-04       Impact factor: 4.050

6.  RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist.

Authors:  D W Bonhaus; L A Flippin; R J Greenhouse; S Jaime; C Rocha; M Dawson; K Van Natta; L K Chang; T Pulido-Rios; A Webber; E Leung; R M Eglen; G R Martin
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

7.  Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.

Authors:  Mary Courtney Moore; Kazuhiro Kimura; Haruki Shibata; Tsutomu Honjoh; Masayuki Saito; Carrie A Everett; Marta S Smith; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-03-08       Impact factor: 4.310

8.  JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.

Authors:  Colleen L Mayberry; Ashley N Soucy; Conner R Lajoie; Jeanne K DuShane; Melissa S Maginnis
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

9.  Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.

Authors:  Antony R Knight; Anil Misra; Kathleen Quirk; Karen Benwell; Dean Revell; Guy Kennett; Mike Bickerdike
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-30       Impact factor: 3.000

10.  Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.

Authors:  M J Enguix; L Sánchez; M Villazón; J Brea; H Tristán; H J Caruncho; M I Cadavid; M I Loza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.